- US11596692utility2023PD-L1/STING Conjugates and Methods of Use0 cites
- US11590137utility2023Ruxolitinib Formulation for Reduction of Itch in Atopic Dermatitis0 cites
- US11590138utility2023Topical Treatment of Vitiligo by a Jak Inhibitor0 cites
- US11591318utility2023Bipyrazole Derivatives as JAK Inhibitors0 cites
- US11591329utility2023Bicyclic Heterocycles as FGFR Inhibitors0 cites
- US11591338utility2023Pyrrolotriazine Compounds as TAM Inhibitors0 cites
- US11584961utility2023Biomarkers for Inflammatory Skin Disease0 cites
- US11572366utility2023Heterocyclic Compounds as Immunomodulators0 cites
- US11566026utility2023Heterocyclic Compounds as Immunomodulators0 cites
- US11566028utility2023Bicyclic Heterocycles as FGFR Inhibitors0 cites
- US11542265utility2023Pyrazolopyrimidine Compounds and Uses Thereof0 cites
← PreviousPage 8 of 8